Tucatinib 150 Mg Tablet Tucaliv

About Tucatinib 150 Mg Tablet Tucaliv

Tucatinib 150 mg Tablets are a targeted anti-cancer medication used in the treatment of HER2-positive breast cancer, particularly in advanced or metastatic cases. Tucatinib is a selective tyrosine kinase inhibitor that specifically targets the HER2 receptor, helping to slow the growth and spread of cancer cells while minimizing effects on healthy cells.

Composition:

• Active Ingredient: Tucatinib

• Strength: 150 mg

• Dosage Form: Tablet

Therapeutic Use:

• Treatment of HER2-positive metastatic breast cancer

• Used in combination with other anti-cancer medicines as prescribed by an oncologist

Mechanism of Action:
Tucatinib selectively inhibits the HER2 tyrosine kinase, blocking cancer cell signaling pathways responsible for tumor growth and survival. Its high selectivity helps reduce off-target side effects compared to non-selective HER2 inhibitors.

Key Benefits:

• Targeted HER2 inhibition

• Effective in advanced and metastatic breast cancer

• Suitable for long-term oral therapy

• Clinically proven efficacy when used in combination regimens

Dosage & Administration:

• Dosage should be taken strictly as directed by a qualified oncologist

• Tablets should be swallowed whole with water

• Do not crush or chew

Storage Instructions:

• Store in a cool, dry place

• Protect from light and moisture

• Keep out of reach of children

Packaging:

• Strip / Bottle packing (as available)

Prescription Status:

• Prescription drug (Rx only)

Disclaimer:
This product is intended for use under the supervision of a registered medical practitioner. Dosage and treatment duration depend on the patients clinical condition.

Targeted Oncology for HER2-Positive Breast Cancer

Tucaliv (Tucatinib 150 mg) is tailored for adults diagnosed with HER2-positive metastatic breast cancer. By inhibiting the HER2 protein, this therapy offers a highly focused approach that can help interrupt cancer cell growth, supporting improved clinical outcomes when used as directed in oncology treatment regimens.


Easy Oral Administration and Efficient Dosing

Designed for convenience, each Tucaliv tablet is administered orally, simplifying treatment for patients. With standard packaging of 30 tablets per box, Tucaliv supports consistent therapy adherence. Physicians will determine your individual dosing schedule, making it vital to follow instructions precisely for optimal benefit.


Safe Storage and Handling Practices

Keep Tucaliv tablets in a cool, dry place below 30C and protect them from moisture. Always store them out of the reach of children. Proper storage ensures the medicine maintains its efficacy and safety throughout its shelf life, contributing to the overall success of your treatment plan.